A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate adequate-dose of DW-3102 in the treatment of
hypercholesterolemia patients by conducting phase 2a. 4 groups involving placebo group, each
groups are composed by 16, will be participated in this trial.